T3+ and T4 Rectal Cancer Patients Seem to Benefit From the Addition of Oxaliplatin to the Neoadjuvant Chemoradiation Regimen

201126 citationsJournal Article

Authors

Good health and well-being

Published in: Annals of Surgical Oncology

Volume 19, Issue 2, pp. 392-401

Field-Weighted Citation Impact: 1.83